Similar Items: Clinical outcomes of immune checkpoint inhibitor based therapy in NRG1 fusion positive non small cell lung cancer a retrospective study
- Peripheral blood IFN-γ–producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor–based therapy
- Clinical outcomes of concomitant anti-PD-1 therapy and denosumab treatment in non-small cell lung cancer patients with bone metastasis: a single-center retrospective study
- Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer
- Fascin-1 expression in non-small cell lung cancer and its diagnostic implications
- Proteomic stratification reveals immune metabolic heterogeneity in lung adenocarcinoma
- An overview of circular RNAs in the regulation of autophagy in lung cancer